OAGB 2025. A systematic review with meta-analysis of indications and results for primary procedures at 5+ years - Takeaways - MDSpire

OAGB 2025. A systematic review with meta-analysis of indications and results for primary procedures at 5+ years

  • By

  • Mario Musella

  • Sonja Chiappetta

  • Antonio Franzese

  • Pasquale Avella

  • Vincenzo Schiavone

  • Alessandra D’Ambrosio

  • Lucrezia Borrelli

  • Gerardo D’Amato

  • October 2, 2025

  • 0 min

Share

  • 1

    One-anastomosis gastric bypass (OAGB) is a widely recognized metabolic and bariatric procedure endorsed by major surgical organizations.

  • 2

    OAGB demonstrates effective long-term weight loss and improved metabolic outcomes, including significant reductions in HbA1c and higher T2DM remission rates.

  • 3

    Long-term complications associated with OAGB include bile reflux, malnutrition, and vitamin deficiencies, raising concerns about its safety.

  • 4

    The rate of revisional surgery after OAGB is relatively low, despite reports of increased GERD and complications requiring conversion to RYGB.

  • 5

    This systematic review and meta-analysis evaluated studies on OAGB outcomes, focusing on long-term results and patient selection criteria.

Original Source(s)

Related Content